JOHN ERWIN: Open Payments
NPI 1518906858 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 74 payments from 19 companies in 2025. Trend: 2023 $1,957 · 2024 $1,458 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $329 |
| ABBVIE INC. | 20 | $308 |
| AstraZeneca Pharmaceuticals LP | 6 | $200 |
| Actelion Pharmaceuticals US, Inc. | 2 | $142 |
| Novo Nordisk Inc | 1 | $121 |
| PFIZER INC. | 5 | $88 |
| Amgen Inc. | 5 | $74 |
| Antares Pharma, Inc. | 4 | $67 |
| Abbott Laboratories | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
Products named: REXULTI, AIRSUPRA, VRAYLAR, UPTRAVI, Ozempic, UBRELVY, NURTEC ODT, XYOSTED.
Industry payments across AR — which companies pay providers there.
